Neurocrine Receives Approvable Letter for Indiplon Capsules with

MSN MoneyCentral - The product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, endometriosis, irritable bowel syndrome, pain, and diabetes. Indiplon was licensed from DOV Pharmaceutical in 1998 Read more